Comprehensive evaluation of the development of traditional Chinese medicine industry in Shaanxi province based on PMC index model.

BACKGROUND

The high-quality development of the traditional Chinese medicine (TCM) industry is dependent on supportive policies and requires higher levels of coordination and integration. National and local government policies must coordinate the integrated development of the TCM industry under modern governance principles. However, the policy structure and its impact on the development of the TCM industry have not been thoroughly explored from the perspectives of policy design and empirical evidence.

METHODS

A TCMIDPs evaluation system was established using the PMC-Index model to quantitatively analyze TCMIDPs in China and Shaanxi Province. Additionally, principal component analysis (PCA) was used to comprehensively evaluate 51 enterprises in Shaanxi Province.

RESULTS

The policy analysis shows that the average PMC index of the 31 TCM industry development policies is 5.080, indicating that the areas and functions covered by these policies need improvement. The comprehensive evaluation reveals that pharmaceutical enterprises in Shaanxi Province still exhibit unbalanced development.

CONCLUSION

Future TCM industry policies should focus on long-term industrial development, incorporating comprehensive perspectives. Emphasis should be placed on strengthening enterprise R&D, accelerating pharmaceutical innovation, and promoting the holistic development of pharmaceutical enterprises.